Palivizumab, sold under the brand name Synagis, is a monoclonal antibody produced by recombinant DNA technology used to prevent severe disease caused...

measures for RSV disease remain limited to good hygiene and the use of palivizumab, a monoclonal antibody used only for high-risk children, including premature...

study showed that nirsevimab had a similar safety profile compared to palivizumab (Synagis). The US Food and Drug Administration (FDA) evaluated the safety...

inhibitor, and has shown good results in Phase II and III clinical trials. Palivizumab Presatovir Lumicitabine Zheng X, Gao L, Wang L, Liang C, Wang B, Liu...

advocating for equity for Indigenous children, including the RSV antibody palivizumab, and for better housing, access to clean water and solutions to food...

large-cell lymphoma in 2011. In 1998, the FDA approved the medical use of palivizumab (trade name: Synagis), which is a humanized monoclonal antibody used...

Isosorbide mononitrate Metoprolol Motavizumab Olaparib Omeprazole Osimertinib Palivizumab Propofol Quetiapine Ravulizumab Roflumilast Rosuvastatin Roxadustat...

Isosorbide mononitrate Metoprolol Motavizumab Olaparib Omeprazole Osimertinib Palivizumab Propofol Quetiapine Ravulizumab Roflumilast Rosuvastatin Roxadustat...

as they enter their second RSV season. A second monoclonal antibody, Palivizumab, can be administered to prevent bronchiolitis to infants less than one...

pandemic immunotherapy, targets spike protein of SARS-CoV-2 human Other palivizumab RSV infections in children inhibits an RSV fusion (F) protein humanized...